Metraipolis › archive › dc_7111f0eb46b9
Phase I Clinical Study with the GRPR-Antagonist [99mTc]Tc-DB8 for SPECT Imaging of Prostate Cancer: Does the Injected Peptide Mass Make a Difference? — Europe PMC PMID:41155959
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41155959
- DOI
- 10.3390/pharmaceutics17101323
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T09:37:58.079Z
- SHA-256 of the archived text
ecc9241297ef424e0b73a568ffbc9417782f6ed725df5089ed08b8a6f0c71ac3- Stable URL of this page
https://metraipolis.com/documento/dc_7111f0eb46b9
How to cite
Phase I Clinical Study with the GRPR-Antagonist [99mTc]Tc-DB8 for SPECT Imaging of Prostate Cancer: Does the Injected Peptide Mass Make a Difference? — Europe PMC PMID:41155959 — Europe PMC (en), https://europepmc.org/article/MED/41155959 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7111f0eb46b9 (Metraipolis archive dc_7111f0eb46b9, sha256 ecc9241297ef424e0b73a568ffbc9417782f6ed725df5089ed08b8a6f0c71ac3)
BibTeX
@misc{dc7111f0eb46b9,
title = {Phase I Clinical Study with the GRPR-Antagonist [99mTc]Tc-DB8 for SPECT Imaging of Prostate Cancer: Does the Injected Peptide Mass Make a Difference? — Europe PMC PMID:41155959},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41155959},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7111f0eb46b9; sha256 ecc9241297ef424e0b73a568ffbc9417782f6ed725df5089ed08b8a6f0c71ac3},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41155959. Agents can read the archived copy with the MCP tool read_document.